Guest content from Sandy Graham, managing partner at Sequoyah Associates: A Business Plan is the single most important document you will develop in establishing and growing your business. How your business plan is developed is certainly up to you. Either you can take the time to develop your plan, or you can work with one […]
BiotechBistro.com is a new biotechnology community forum attached to BiotechBlog. Topic titles from BiotechBistro are listed on the BiotechBlog homepage (look down the left sidebar), making it an excellent outlet to start productive discussions or announce new products. BiotechBistro is available for introductions, networking, posting press releases, and job opening/availability postings.
For a comprehensive review of biotech happenings in 2008 and visions for 2009, check out BioProcess International’s recent article “2008 in Review.” This article features interviews with me and a number of other industry insiders about our relections on events in 2008, and projections for what the future will bring.
After months of effort, I’m pleased to announce the launch of Biotech U, a biotechnology education resource featuring web-based lessons on biotechnology business, law, IP, politics, regulations, and science. Biotech U is based on Building Biotechnology, the leading text used in business-of-biotechnology courses. The online-learning structure is designed to meet the needs of busy professionals […]
Courtesy of DrugPatentWatch.com: Drug Patent Expirations in January 2009 *Drugs may be covered by multiple patents
The January 2009 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Volume 15, Issue 1 Editorial Biotechnology commercialisation: Getting past the technology-push PDF Yali Friedman Articles Record integrity and licensing your intellectual property PDF John Avellanet NIH assistance for new therapeutic […]
Last week I sent an update to my list of biotech educators about the availability of instructor resources for Building Biotechnology. I’m starting to see interest among educators who I didn’t email, so I ‘m posting a follow-up here to spread the word. The instructor resources are free for qualified educators and include figures and […]
Emergent biotechnology companies are very reliant on capital, often having less than two years capital on hand. Like other businesses with strong needs for cash, one would expect biotechnology companies to be adversely effected by a dearth of capital. The biotechnology financial crisis and request for pass-forward tax breaks have been covered elsewhere; I’ve been […]
I’m working on an International Biotechnology ranking and comparison for a well-known publication, and am looking for data sets comparing biotechnology activities in different countries as well as interesting anecdotes about successes/failures/challenges encountered in developing biotechnology in different countries as well between countries. If you’ve got comparative data sets or interesting anecdotes, please drop me […]
Courtesy of DrugPatentWatch.com: Drug Patent Expirations in December 2008 *Drugs may be covered by multiple patents